NCT03137121View on ClinicalTrials.gov

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 12, 2017

Primary Completion Date

July 12, 2019

Study Completion Date

September 15, 2020

Conditions
Advanced Cancer
Interventions
DRUG

Olanzapine

Olanzapine is used as an anti-emetic.

OTHER

Placebo

The placebo is a non-anti-emetic.

Trial Locations (5)

35294

University of Alabama at Birmingham, Birmingham

46202

Indiana University, Indianapolis

54301

Hospital Sisters Health System (HSHS) St. Vincent Hospital, Green Bay

55905

Mayo Clinic, Rochester

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

University of Alabama at Birmingham

OTHER